|
|
Volumn 105, Issue 5 I, 2005, Pages 1136-1137
|
|
Topiramate (Topamax) for prevention of migraine [1]
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BICARBONATE;
BOTULINUM TOXIN;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
ESTROGEN;
METOPROLOL TARTRATE;
NADOLOL;
PHENYTOIN;
PROPRANOLOL;
PROPRANOLOL DERIVATIVE;
TIMOLOL MALEATE;
TOPIRAMATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROATE SEMISODIUM;
VERAPAMIL;
BICARBONATE BLOOD LEVEL;
BLEEDING;
CLINICAL TRIAL;
CLOSED ANGLE GLAUCOMA;
COGNITIVE DEFECT;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG DOSE REGIMEN;
FATIGUE;
FRACTURE;
HAIR LOSS;
HUMAN;
HYPERAMMONEMIA;
LETTER;
LIBIDO DISORDER;
LIVER FAILURE;
METABOLIC ACIDOSIS;
MIGRAINE;
MYOPIA;
NAUSEA;
NEPHROLITHIASIS;
ORTHOSTATIC HYPOTENSION;
OVARY POLYCYSTIC DISEASE;
PANCREATITIS;
PARESTHESIA;
PRIORITY JOURNAL;
PSYCHOMOTOR DISORDER;
SIDE EFFECT;
TASTE DISORDER;
TREMOR;
WEIGHT GAIN;
WEIGHT REDUCTION;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FRUCTOSE;
HUMANS;
INCIDENCE;
MIGRAINE DISORDERS;
PREGNANCY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 17644386213
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1097/01.AOG.0000160768.23764.0a Document Type: Letter |
|
Times cited : (3)
|
|
References (8)
|
